相关实验视频
Updated: Jul 30, 2026
09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.0K
工程和设计有希望的基于T细胞的多表位组疫苗候选人,以对抗莱什曼病
Esmaeil Roohparvar Basmenj1, Mahshid Arastonejad2, Mina Mamizadeh3,4
1Biophysics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Scientific reports
|November 8, 2023
概括
使用in silico方法设计了两种新的基于T细胞的皮肤莱什曼病 (CL) 候选疫苗. 这些候选人,Leish-App和Leish-Rpf,显示出对引起强大的免疫反应的承诺.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 疫苗开发 疫苗开发
背景情况:
- 皮肤莱什曼病 (CL) 是亚热带地区普遍存在的寄生虫感染.
- 几十年来,开发针对CL的有效疫苗面临着重大挑战.
- 需要基于T细胞的新型疫苗策略来克服现有的局限性.
研究的目的:
- 设计和评估基于T细胞的新型候选疫苗,以对抗皮肤莱什曼病 (CL).
- 为了识别来自Leishmania主要抗原的强有力的表位碎片,以诱导细胞介导免疫.
- 通过计算来评估设计的疫苗结构的免疫性和结构稳定性.
主要方法:
- 从关键的L.主要抗原中选择了排名最高的人类白细胞抗原 (HLA) 特定的IFN-γ诱导,CD4+和CD8+T细胞表皮质结合剂.
- 生成的多表位疫苗结构,包含不同的间隔剂和辅助剂 (RS-09,RpfE).
- 用于体免疫模拟,与TLR-4的分子对接,分子动力学和密码子优化.
主要成果:
- 两个候选疫苗,Leish-App (具有RS-09) 和Leish-Rpf (具有RpfE),在模拟中显示出强大的免疫反应.
- 分子对接和动力学模拟证实了Leish-App与人类TLR-4的稳定相互作用.
- 已成功将codon优化的构造物连接到pET28a(+) 矢量中,为进一步的实验验证做好准备.
结论:
- 通过使用全面的in silico方法,成功设计了两种针对CL的强效多位候选疫苗.
- 莱什-App和莱什-Rpf显示出作为CL疫苗进一步开发的巨大潜力.
- 建议进行进一步的实验验证 (湿实验),以确认这些候选疫苗的疗效.
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...